WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 70.20
-1.10 (-1.54%)
Jan 22, 2026, 1:00 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.24 billion as of January 21, 2026. Its market cap has decreased by -2.52% in one year.
Market Cap
3.24B
Enterprise Value
3.81B
Revenue
1.06B
Ranking
n/a
PE Ratio
16.47
Stock Price
70.20
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.24B, a decrease of -5.47%. That is a compound annual growth rate of -2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 3.24B | -2.86% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCmed Innovations | 4.86B |
| Bonraybio | 3.94B |
| Medimaging Integrated Solution | 3.38B |
| InnoCare Optoelectronics | 2.86B |
| A Plus Biotechnology | 2.76B |
| Diamond Biotechnology | 2.62B |
| Applied BioCode | 2.46B |
| Dynamic Medical Technologies | 2.40B |